The notable advances on interstitial lung disease (ILD) published in Chinese and international authoritative journals from October 2023 to September 2024 were systematically reviewed in this annual review. Advances on pathogenesis, diagnosis, treatment, global and/or Chinese comments and guidelines of idiopathic pulmonary fibrosis, connective tissue disease-associated ILD and sarcoidosis were reviewed in detail in our paper.
本文系统复习了自2023年10月至2024年9月期间、国内外权威杂志中间质性肺疾病诊疗相关的文献，重点关注特发性肺纤维化、结缔组织疾病相关性间质性肺疾病和结节病等疾病，内容上主要涉及上述疾病的发病机制、诊断和治疗进展以及其权威诊疗共识、指南。.